April 8, 2022
April 8, 2022
As of the latest update by the Greek authorities, the total number of confirmed Covid-19 diagnosed cases in Greece 3,137,714. 76 new deaths were reported raising the total number to 27,968. The number of patients treated in intensive care units is currently 359. 10,858 new cases were announced yesterday in Greece. 4,372 of the new cases were found in the Attica region and 1,074 new cases in the Thessaloniki region.
The platform to book an appointment for the fourth dose against Covid-19 opened on Thursday for people over 80 years of age.
The opening of the platform will be gradual, dividing eligible citizens by decade. After making it available for 80-year-olds, the platform will gradually open for the age group 70-79 and then for 60-69-year-olds.
The beneficiaries of the second booster dose are about 1.3 million citizens over the age of 60.
The decision for a second booster shot came after the recommendation of the National Vaccination Committee. The committee recommends the administration of the second booster dose with Pfizer and Moderna mRNA vaccine, at least 4 months after vaccination with the first booster dose (3rd dose).
A second booster dose is not recommended for people who got Covid after the first booster dose.
EU health agencies said on Wednesday there was no evidence to support the use of a fourth dose of Covid-19 vaccines developed by Pfizer and Moderna in the general population, but they recommend a second booster for people aged 80 and above.
There is no clear evidence in the European Union that vaccine protection against severe disease is waning substantially in adults with normal immune systems aged 60-79, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) said in a joint statement.
They cautioned, however, that it may become necessary to consider a fourth dose in this age group if the epidemiological situation changes.
Both agencies agreed a fourth dose can be given to adults 80 years of age and above.
That recommendation came a week after European health ministers urged the bloc’s executive to back a fourth Covid-19 shot for people over 60 to boost immunity in the absence of vaccines that specifically protect against the Omicron variant.
A study from Israel has shown that senior citizens who received a second booster of the Pfizer-BioNTech Covid-19 vaccination had a 78% lower mortality rate from the disease than those who had only one.
The agencies said there was no conclusive evidence of “an added value of a fourth dose” in those aged below 60.
The agencies will consider the best timing for additional doses, possibly taking advantage of updated vaccines when re-vaccination campaigns start in the autumn.
In more detail, the 10,858 new cases detected per Regional Unit: